DLocal Limited delivered record 2025 results, surpassing $1B in revenue and $191M in adjusted free cash flow, with no debt and $720M in cash. DLO's TPV grew from $9.2B in Q2 to $13.1B in Q4, and ...
Management indicated the pivotal and ASPIRE trials are "on track to complete dosing in the second quarter of 2026." The company expects to initiate BLA-enabling process performance qualification (PPQ) ...